ArticleFrontiers in psychiatry2025
Symptoms of depression in middle-aged and older adults with schizophrenia in Guangzhou, China: a cross-sectional study.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore the prevalence and risk factors of symptoms of depression in middle-aged and older adults with schizophrenia. Methods: In this cross-sectional study, 116 participants were recruited from a tertiary psychiatric hospital in Guangzhou, China. The sample consisted of adults aged 40 years and over. Based on their scores on the Geriatric Depression Scale, participants with schizophrenia were categorized into two groups: those with depressive symptoms (scores greater than 10 points) and those without depressive symptoms (scores of 10 points or lower). This study compared the differences in the sociodemographic variables (such as gender, age, education level, marital status, and BMI) and the clinical characteristics (e.g., suicide risk, anxiety level, severity of mental symptoms, insight into illness and treatment attitude, cognitive function, activities of daily living, quality of life, and social support) between two groups. Spearman's correlation analysis and logistic regression analysis were employed to explore the relevant factors contributing to depression in middle-aged and older adults with schizophrenia. Results: The participants had an average age of 63.28 ± 7.87 years, and 88 of the participants (75.9%) are women. Among them, 34 participants (29.31%) exhibited symptoms of depression. Statistically significant differences were observed between the two groups in the affect and resistance sub-dimensions of the Brief Psychiatric Rating Scale (BPRS) and the total scores of the Generalized Anxiety Disorder (GAD) assessment, the Insight and Treatment Attitudes Questionnaire (ITAQ), the Nurses' Global Assessment of Suicide Risk (NGASR), and the Schizophrenia Quality of Life Scale (SQLS). Furthermore, logistic regression indicated that the resistance sub-dimension of the BPRS (OR = 0.790, 95%CI = 0.648-0.963) and the SQLS (OR = 1.115, 95%CI = 1.055-1.178) and GAD scores (OR = 1.205, 95%CI = 1.029-1.412) are predictive factors for symptoms of depression in individuals with schizophrenia. Conclusion: In middle-aged and older adults with schizophrenia, affective symptoms and quality of life are associated with symptoms of depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.